Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/43279
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fokas, Emmanouil | - |
dc.contributor.author | Smith, J. Joshua | - |
dc.contributor.author | Garcia-Aguilar, Julio | - |
dc.contributor.author | Glynne-Jones, Robert | - |
dc.contributor.author | BUYSE, Marc | - |
dc.contributor.author | Roedel, Claus | - |
dc.date.accessioned | 2024-06-26T12:46:12Z | - |
dc.date.available | 2024-06-26T12:46:12Z | - |
dc.date.issued | 2024 | - |
dc.date.submitted | 2024-06-26T10:57:20Z | - |
dc.identifier.citation | Journal of clinical oncology, 42 (8) , p. 872 -875 | - |
dc.identifier.uri | http://hdl.handle.net/1942/43279 | - |
dc.description.abstract | Trial-level surrogacy is critical before early response endpoints are used to approve new therapies. | - |
dc.description.sponsorship | All authors (E.F., J.J.S., J.G.-A., R.G.-J., M.B., and C.R.) contributed to literature search and writing or review of the manuscript and approved the final manuscript. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.rights | 2023 by American Society of Clinical Oncology. Free access | - |
dc.subject.other | Humans | - |
dc.subject.other | Treatment Outcome | - |
dc.subject.other | Neoadjuvant Therapy | - |
dc.subject.other | Rectal Neoplasms | - |
dc.title | Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 875 | - |
dc.identifier.issue | 8 | - |
dc.identifier.spage | 872 | - |
dc.identifier.volume | 42 | - |
local.format.pages | 5 | - |
local.bibliographicCitation.jcat | A2 | - |
dc.description.notes | Fokas, E (corresponding author), Goethe Univ Frankfurt, Dept Radiotherapy & Oncol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. | - |
dc.description.notes | emmanouil.fokas@kgu.de | - |
local.publisher.place | TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Editorial Material | - |
dc.identifier.doi | 10.1200/JCO.23.01196 | - |
dc.identifier.pmid | 37890124 | - |
dc.identifier.isi | 001233983000011 | - |
dc.contributor.orcid | Smith, Jesse Joshua/0000-0003-2538-5456; FOKAS, | - |
dc.contributor.orcid | EMMANOUIL/0000-0003-1601-6165; Glynne-Jones, Rob/0000-0002-6742-222X | - |
local.provider.type | wosris | - |
local.description.affiliation | [Fokas, Emmanouil; Roedel, Claus] Goethe Univ Frankfurt, Dept Radiotherapy & Oncol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. | - |
local.description.affiliation | [Fokas, Emmanouil; Roedel, Claus] German Canc Res Ctr, Heidelberg, Germany. | - |
local.description.affiliation | [Fokas, Emmanouil; Roedel, Claus] Partner Site Frankfurt, German Canc Consortium DKTK, Frankfurt, Germany. | - |
local.description.affiliation | [Fokas, Emmanouil; Roedel, Claus] Frankfurt Canc Inst FCI, Frankfurt, Germany. | - |
local.description.affiliation | [Fokas, Emmanouil] Univ Hosp Cologne, Fac Med, Dept Radiat Oncol Cyberknife & Radiotherapy, Cologne, Germany. | - |
local.description.affiliation | [Smith, J. Joshua; Garcia-Aguilar, Julio] Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, New York, NY USA. | - |
local.description.affiliation | [Glynne-Jones, Robert] Mt Vernon Ctr Canc Treatment, Dept Radiotherapy, Northwood, Middlesex, England. | - |
local.description.affiliation | [Buyse, Marc] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium. | - |
local.description.affiliation | [Buyse, Marc] Int Drug Dev Inst, San Francisco, CA USA. | - |
local.uhasselt.international | yes | - |
item.accessRights | Open Access | - |
item.contributor | Fokas, Emmanouil | - |
item.contributor | Smith, J. Joshua | - |
item.contributor | Garcia-Aguilar, Julio | - |
item.contributor | Glynne-Jones, Robert | - |
item.contributor | BUYSE, Marc | - |
item.contributor | Roedel, Claus | - |
item.fullcitation | Fokas, Emmanouil; Smith, J. Joshua; Garcia-Aguilar, Julio; Glynne-Jones, Robert; BUYSE, Marc & Roedel, Claus (2024) Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited. In: Journal of clinical oncology, 42 (8) , p. 872 -875. | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 0732-183X | - |
crisitem.journal.eissn | 1527-7755 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fokas-et-al-2023-early-efficacy-end-points-in-neoadjuvant-rectal-cancer-trials-surrogacy-revisited.pdf | Published version | 354.06 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.